Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

"Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?" Letter to the editor reply.

Coon EA, Laughlin RS.

J Headache Pain. 2012 Nov;13(8):687. doi: 10.1007/s10194-012-0487-9. Epub 2012 Oct 5. No abstract available.

2.

Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?

Coon EA, Laughlin RS.

J Headache Pain. 2012 Apr;13(3):255-7. doi: 10.1007/s10194-012-0421-1. Epub 2012 Feb 10.

3.

[Dopamine dysregulation syndrome in a patient with Parkinson's disease; a case report].

Hol WM, van der Zwaard R, Hovestadt A, van Megen HJ.

Tijdschr Psychiatr. 2010;52(4):259-63. Dutch.

4.

Drug-induced burning mouth syndrome: a new clinico-pathological entity?

Fortuna G, Pollio A.

J Headache Pain. 2012 Nov;13(8):685-6. doi: 10.1007/s10194-012-0486-x. Epub 2012 Sep 30. No abstract available.

5.

Compulsive use of dopamine replacement therapy in Parkinson's disease: insights into the neurobiology of addiction.

Brown RM, Lawrence AJ.

Addiction. 2012 Feb;107(2):250-1. doi: 10.1111/j.1360-0443.2011.03641.x. No abstract available.

PMID:
22248133
6.

Fever and rigidity.

Howard ZD, Rempell JS, Nadel ES, Brown DF.

J Emerg Med. 2011 Jun;40(6):668-70. doi: 10.1016/j.jemermed.2010.10.015. Epub 2010 Nov 13. No abstract available.

PMID:
21074960
7.

Addiction as aberrant learning-evidence from Parkinson's disease.

Dagher A.

Addiction. 2012 Feb;107(2):248-50. doi: 10.1111/j.1360-0443.2011.03624.x. No abstract available.

PMID:
22248132
8.

Compulsive use of dopamine replacement therapy among Parkinson's disease patients: if it looks like a duck, swims like a duck and quacks like a duck...

Kaye S.

Addiction. 2012 Feb;107(2):251-3. doi: 10.1111/j.1360-0443.2011.03679.x. No abstract available.

PMID:
22248134
9.

Lees' syndrome: a case series.

Becker N, Munhoz RP, Teive HA.

Arq Neuropsiquiatr. 2011 Oct;69(5):756-9.

10.

[Current aspects in the therapy of Parkinson's Syndrome].

Ceballos-Baumann A.

Krankenpfl J. 1991 Jul-Aug;29(7-8):310-4. German. No abstract available.

PMID:
1681135
11.
12.

Factors influencing dopaminergic therapy of Parkinson's disease.

Horowski R.

Funct Neurol. 1988 Oct-Dec;3(4):459-70. Review. No abstract available.

PMID:
2907501
13.

Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy.

Voon V, Dalley JW.

Nat Rev Neurol. 2011 Sep 13;7(10):541-2. doi: 10.1038/nrneurol.2011.139. No abstract available.

PMID:
21912409
14.

[Diagnosis and therapy of Parkinson's disease].

Wittstock M, Benecke R.

MMW Fortschr Med. 2005 May 17;147 Spec No 2:28-31. German.

PMID:
15968869
15.
16.

Recent advances in Parkinson's disease.

VĂ©csei L.

Ideggyogy Sz. 2002 Nov 20;55(11-12):406-7. Review. No abstract available.

PMID:
12632802
17.

Neuroprotection for Parkinson's disease.

Koller WC.

Ann Neurol. 1998 Sep;44(3 Suppl 1):S155-9. Review.

PMID:
9749588
18.

Medications for Parkinson's disease.

Whitney CM.

Neurologist. 2007 Nov;13(6):387-8. No abstract available.

PMID:
18090719
19.

Compulsive singing: another aspect of punding in Parkinson's disease.

Bonvin C, Horvath J, Christe B, Landis T, Burkhard PR.

Ann Neurol. 2007 Nov;62(5):525-8.

PMID:
17696122
20.

Evidence-based initiation of dopaminergic therapy in Parkinson's disease.

Miyasaki JM.

J Neurol. 2010 Nov;257(Suppl 2):S309-13. doi: 10.1007/s00415-010-5718-x. Review.

PMID:
21080195

Supplemental Content

Support Center